Search research articles
Contact Us
Filters
Showing results (41-50 of 136) with videos related to
Page
of 14
Sort By:
Annals of Internal Medicine
|
September 7, 2020
A Novel Histiocytosis With Synovial and Skin Involvement
Giulio Cavalli, Giacomo De Luca, Claudio Doglioni, et al.
Clinical and Experimental Rheumatology
|
March 29, 2022
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease
Corrado Campochiaro, Nicola Farina, Alessandro Tomelleri, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
October 27, 2020
Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
Francesco Benedetti, Mario Mazza, Giulio Cavalli, et al.
Annals of the Rheumatic Diseases
|
February 12, 2013
The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases
Giulio Cavalli, Barbara Guglielmi, Alvise Berti, et al.
Annals of the Rheumatic Diseases
|
December 11, 2019
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease
Corrado Campochiaro, Giulio Cavalli, Nicola Farina, et al.
Frontiers in Immunology
|
February 25, 2017
Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure
Giulio Cavalli, Marco Foppoli, Luca Cabrini, et al.
International Journal of Cardiology
|
June 1, 2017
QTc interval prolongation in Systemic Sclerosis: Correlations with clinical variables and arrhythmic risk
Giacomo De Luca, Silvia Laura Bosello, Giovanni Canestrari, et al.
Journal of Leukocyte Biology
|
February 15, 2020
Erdheim-Chester disease: An in vivo human model of Mϕ activation at the crossroad between chronic inflammation and cancer
Giulio Cavalli, Lorenzo Dagna, Riccardo Biavasco, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
January 4, 2021
Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
Francesco Benedetti, Mario Gennaro Mazza, Giulio Cavalli, et al.
Seminars in Arthritis and Rheumatism
|
February 24, 2020
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis
Corrado Campochiaro, Alessandro Tomelleri, Silvia Sartorelli, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 136) with videos related to
Sort By:
Page
of 14
Annals of Internal Medicine
|
September 7, 2020
A Novel Histiocytosis With Synovial and Skin Involvement
Giulio Cavalli, Giacomo De Luca, Claudio Doglioni, et al.
Clinical and Experimental Rheumatology
|
March 29, 2022
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease
Corrado Campochiaro, Nicola Farina, Alessandro Tomelleri, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
October 27, 2020
Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
Francesco Benedetti, Mario Mazza, Giulio Cavalli, et al.
Annals of the Rheumatic Diseases
|
February 12, 2013
The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases
Giulio Cavalli, Barbara Guglielmi, Alvise Berti, et al.
Annals of the Rheumatic Diseases
|
December 11, 2019
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease
Corrado Campochiaro, Giulio Cavalli, Nicola Farina, et al.
Frontiers in Immunology
|
February 25, 2017
Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure
Giulio Cavalli, Marco Foppoli, Luca Cabrini, et al.
International Journal of Cardiology
|
June 1, 2017
QTc interval prolongation in Systemic Sclerosis: Correlations with clinical variables and arrhythmic risk
Giacomo De Luca, Silvia Laura Bosello, Giovanni Canestrari, et al.
Journal of Leukocyte Biology
|
February 15, 2020
Erdheim-Chester disease: An in vivo human model of Mϕ activation at the crossroad between chronic inflammation and cancer
Giulio Cavalli, Lorenzo Dagna, Riccardo Biavasco, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
January 4, 2021
Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
Francesco Benedetti, Mario Gennaro Mazza, Giulio Cavalli, et al.
Seminars in Arthritis and Rheumatism
|
February 24, 2020
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis
Corrado Campochiaro, Alessandro Tomelleri, Silvia Sartorelli, et al.
Page
of 14